Sanguinarine: an alkaloid with promising in vitro and in vivo antiparasitic activity against different developmental stages of Schistosoma mansoni and in silico pharmacokinetic properties (ADMET)
The objective of the study was to evaluate the in vitro and in vivo schistosomicidal activity of sanguinarine (SA) on Schistosoma mansoni and its in silico pharmacokinetic parameters. ADMET parameters and oral bioavailability were evaluated using the PkCSM and SwissADME platforms, respectively. The activity of SA in vitro, at the concentrations of 1.0–25 µM, was analyzed through the parameters of motility, mortality, and cell viability of the worms at intervals of 3–24 h. Mice were infected with cercariae and treated by gavage with SA (5 mg/kg/day, in a single dose or two doses of 2.5 mg/kg every 12 h for 5 consecutive days) on the 1st (skin schistosomula), 14th (pulmonary schistosomula), 28th (young worms), and 45th (adult worms) days after infection. In vitro and in vivo praziquantel was the control. In vitro, SA showed schistosomicidal activity against schistosomula, young worms, and couples; with total mortality and reduced cell viability at low concentrations and incubation time. In a single dose of 5 mg/kg/day, SA reduces the total worm load by 47.6%, 54%, 55.2%, and 27.1%, and female worms at 52.0%, 39.1%, 52.7%, and 20.2%, respectively, results which are similar to the 2.5 mg/kg/day dose. SA reduced the load of eggs in the liver, and in histopathological and histomorphometric analyses, there was a reduction in the number and volume of hepatic granulomas, which exhibited less inflammatory infiltrate. SA has promising in vitro and in vivo schistosomicidal activity against different developmental stages of S. mansoni, in addition to reducing granulomatous liver lesions. Furthermore, in silico, SA showed good predictive pharmacokinetic ADMET profiles. Graphical Abstract.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:123 |
|---|---|
| Enthalten in: |
Parasitology research - 123(2024), 2 vom: Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
de Souza Silva, Maria Stéphanny [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Histopathology of schistosomiasis |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s00436-024-08153-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR054898617 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR054898617 | ||
| 003 | DE-627 | ||
| 005 | 20240306064645.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00436-024-08153-w |2 doi | |
| 035 | |a (DE-627)SPR054898617 | ||
| 035 | |a (SPR)s00436-024-08153-w-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a de Souza Silva, Maria Stéphanny |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sanguinarine: an alkaloid with promising in vitro and in vivo antiparasitic activity against different developmental stages of Schistosoma mansoni and in silico pharmacokinetic properties (ADMET) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a The objective of the study was to evaluate the in vitro and in vivo schistosomicidal activity of sanguinarine (SA) on Schistosoma mansoni and its in silico pharmacokinetic parameters. ADMET parameters and oral bioavailability were evaluated using the PkCSM and SwissADME platforms, respectively. The activity of SA in vitro, at the concentrations of 1.0–25 µM, was analyzed through the parameters of motility, mortality, and cell viability of the worms at intervals of 3–24 h. Mice were infected with cercariae and treated by gavage with SA (5 mg/kg/day, in a single dose or two doses of 2.5 mg/kg every 12 h for 5 consecutive days) on the 1st (skin schistosomula), 14th (pulmonary schistosomula), 28th (young worms), and 45th (adult worms) days after infection. In vitro and in vivo praziquantel was the control. In vitro, SA showed schistosomicidal activity against schistosomula, young worms, and couples; with total mortality and reduced cell viability at low concentrations and incubation time. In a single dose of 5 mg/kg/day, SA reduces the total worm load by 47.6%, 54%, 55.2%, and 27.1%, and female worms at 52.0%, 39.1%, 52.7%, and 20.2%, respectively, results which are similar to the 2.5 mg/kg/day dose. SA reduced the load of eggs in the liver, and in histopathological and histomorphometric analyses, there was a reduction in the number and volume of hepatic granulomas, which exhibited less inflammatory infiltrate. SA has promising in vitro and in vivo schistosomicidal activity against different developmental stages of S. mansoni, in addition to reducing granulomatous liver lesions. Furthermore, in silico, SA showed good predictive pharmacokinetic ADMET profiles. Graphical Abstract | ||
| 650 | 4 | |a Mice |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Natural product |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Schistosomicidal |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Histopathology of schistosomiasis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Praziquantel |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a dos Santos, Mayara Larissa Melo Ferreira |4 aut | |
| 700 | 1 | |a da Silva, Adriana Maria |4 aut | |
| 700 | 1 | |a França, Wilza Wanessa Melo |4 aut | |
| 700 | 1 | |a Araújo, Sidcley Bernardino |4 aut | |
| 700 | 1 | |a da Silva, Romildo Luciano |4 aut | |
| 700 | 1 | |a do Nascimento, Wheverton Ricardo Correia |4 aut | |
| 700 | 1 | |a da Silva Santos, Noemia Pereira |4 aut | |
| 700 | 1 | |a da Cruz Filho, Iranildo José |4 aut | |
| 700 | 1 | |a de Azevedo Albuquerque, Mônica Camelo Pessoa |4 aut | |
| 700 | 1 | |a de Araújo, Hallysson Douglas Andrade |4 aut | |
| 700 | 1 | |a de Lima Aires, André |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Parasitology research |d Berlin : Springer, 1928 |g 123(2024), 2 vom: Feb. |w (DE-627)SPR005883253 |w (DE-600)1462976-8 |x 1432-1955 |7 nnns |
| 773 | 1 | 8 | |g volume:123 |g year:2024 |g number:2 |g month:02 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00436-024-08153-w |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 123 |j 2024 |e 2 |c 02 | ||